Lensar (LNSR) Asset Writedowns and Impairment (2020 - 2026)
Lensar (LNSR) posted quarterly Asset Writedowns and Impairment of $15000.0 for Q1 2026, down 25.0% year-over-year from $20000.0 in Q1 2025, and up 130.0% quarter-over-quarter from -$50000.0 in Q4 2025.
Lensar (LNSR) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Lensar (LNSR) has reported Asset Writedowns and Impairment for 7 consecutive years, with $15000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 25.0% year-over-year to $15000.0; the TTM figure through Mar 2026 stood at -$5000.0 (down 100.13% YoY), while the FY2024 annual figure was $94000.0, up 42.42% from the prior year.
- Asset Writedowns and Impairment rose to $15000.0 in Q1 2026 per LNSR's latest filing, from -$50000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $3.7 million in Q2 2024 and bottomed at -$50000.0 in Q4 2025.
- Historically, Asset Writedowns and Impairment has averaged $245312.5 across 5 years, with a median of $14000.0 in 2023.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment sank 250.0% — and 2024, when it surged 28584.62%.
- Lensar's Asset Writedowns and Impairment stood at $25000.0 in 2022, then soared by 84.0% to $46000.0 in 2023, then jumped by 54.35% to $71000.0 in 2024, then sank by 170.42% to -$50000.0 in 2025, then jumped by 130.0% to $15000.0 in 2026.
- Business Quant data shows LNSR's Asset Writedowns and Impairment at $15000.0 in Q1 2026, -$50000.0 in Q4 2025, and -$7000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Lensar | 101.76 Mn | 88.19 Mn | 9.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21,000.00 |
| Jun 30, 2026 | 21,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Jun 30, 2024 | 3.73 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Dec 31, 2023 | 46,000.00 |